R&D organization:
Institute of Traditional Chinese Medicine, Chinese Academy of Traditional Chinese Medicine.
Established in 1955, Institute of Traditional Chinese Medicine, Chinese Academy of Traditional Chinese Medicine, is the earliest state-level scientific research institution of traditional Chinese medicine in New China and the traditional medicine cooperation center of the World Health Organization. In 1970s, artemisinin, a new antimalarial drug, became famous all over the world. During the epidemic period of SARS, the project of "Screening and Research on Chinese Medicine for Treating SARS" was completed, which laid a good foundation for optimizing the clinical scheme. In recent years, postgraduate work, mainly in the College of Traditional Chinese Medicine, has won the first place in the country in subject evaluation; In addition, it was awarded the title of "National Advanced Collective of Patent Work" by China National Intellectual Property Administration and the Ministry of Personnel, and it has a very high academic status in the international research field of traditional Chinese medicine.
Guangzhou University of Traditional Chinese Medicine (Pharmaceutical Research and Development Center of Guangzhou University of Traditional Chinese Medicine).
Guangzhou University of Chinese Medicine, founded in 1956, is one of the first four universities of Chinese medicine in China. Deng Tietao, an old Chinese doctor, Wang Jianhua, an expert on spleen and stomach diseases, and Ou Ming, an expert on integrated traditional Chinese and western medicine, are tenured professors. In the national first-class discipline evaluation in 2004, the level of medical first-class discipline ranks first in China, and it is one of the clinical pharmacology research bases of the Ministry of Health and the training bases of Chinese medicine talents, with five key laboratories of the Ministry of Science and Technology. New drug development and research center is the backbone of academic research of traditional Chinese medicine, undertaking a large number of new drug development projects and national key projects, and its research and pilot base has formed a supporting new Chinese medicine innovation chain.